Patents Represented by Attorney, Agent or Law Firm Karen B. King
-
Patent number: 8084481Abstract: The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.Type: GrantFiled: May 21, 2007Date of Patent: December 27, 2011Assignee: Bayer Pharma AktiengesellschaftInventors: Heinrich Meier, Eckhard Bender, Ulf Brüggemeier, Ingo Flamme, Dagmar Karthaus, Peter Kolkhof, Daniel Meibom, Dirk Schneider, Verena Voehringer, Chantal Fürstner, Jörg Keldenich, Dieter Lang, Elisabeth Pook, Carsten Schmeck
-
Patent number: 8058447Abstract: The present application relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, processes for their preparation, pharmaceutical compositions containing them, and their use for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.Type: GrantFiled: July 14, 2006Date of Patent: November 15, 2011Assignee: Bayer Pharma AktiengesellschaftInventors: Alexander Kuhl, Peter Kolkhof, Heike Heckroth, Karl-Heinz Schlemmer, Ingo Flamme, Santiago Figueroa Perez, Heike Gielen-Haertwig, Rolf Grosser, Jens-Kerim Ergüden, Dieter Lang
-
Patent number: 7998988Abstract: The invention relates to biphenyl compounds of formula (I): wherein U, V and W together form a group of the formula *—CH?CH—CH<, *—CH2—CH2—CH< or *—CH2—CH2—N<, in which * means the point of linkage to the phenyl ring; A is O or CH2; and D, E, X, Y, Z, R1, R2, o, n, and p are as defined in the specification. The invention also relates to pharmaceutical compositions of the compound of the compounds. The compounds and pharmaceutical compositions of the invention can be used in the treatment or prevention of cardiovascular disorders.Type: GrantFiled: October 9, 2006Date of Patent: August 16, 2011Assignee: Bayer Schering Pharma AktiengellschaftInventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Klaus Münter, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder
-
Patent number: 7985876Abstract: The invention relates to novel substituted dibenzoic acid derivatives of formula (I), wherein A represents a group of formula (II) or (III), to methods for producing the same, and to their use in the treatment and/or prophylaxis of diseases. The invention also relates to the use of said substances in the production of drugs for the treatment and/or prophylaxis of diseases, especially in the treatment and/or prevention of cardiovascular diseases.Type: GrantFiled: March 15, 2008Date of Patent: July 26, 2011Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Michael Hahn, Eva-Maria Becker, Andreas Knorr, Dirk Schneider, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder, Dieter Lang
-
Patent number: 7906016Abstract: A system includes a first source including a first reactant; a second source including a second reactant capable of reacting with the first reactant to form a first product; and a reactor. The reactor includes a first element having a wall connecting a first point and a second point, the wall extending more than 180° around the first point; and a second element movably engaged with the first element to define a reconfigurable reaction chamber capable of being in fluid communication with the first and second reactants.Type: GrantFiled: August 20, 2008Date of Patent: March 15, 2011Assignee: TIAX LLCInventors: Robert S. Weber, Mark Marion, Jayanti Sinha, William Barney
-
Patent number: 7861541Abstract: In a refrigeration system, an asymmetric scroll expander has an orbiting scroll element engaged with a fixed scroll element. The orbiting scroll element and fixed scroll element can define a first expansion pocket and a second expansion pocket at positions relative to one another.Type: GrantFiled: July 13, 2005Date of Patent: January 4, 2011Assignee: Tiax LLCInventors: John T. Dieckmann, Detlef Westphalen
-
Patent number: 7857616Abstract: A burner apparatus utilizes a reticulated member to promote mixing of a fuel and oxidizer mixture. A plurality of exit ports, disposed on a wall or surface encapsulating the reticulated member, defines exit streams of the mixture that produces flames upon combustion. The burner apparatus have high heating rates and turndown ratios of at least about 18:1.Type: GrantFiled: April 6, 2005Date of Patent: December 28, 2010Assignee: TIAX LLCInventors: Philip C. Carbone, Matthew E. Brekken, Peter F. Pescatore, Charles E. Marble, Matthew Rhodes
-
Patent number: 7029465Abstract: The present invention presents a novel ampoule filtration system, and novel methods and devices for using the system to deliver multi-doses of a sterile solution of a therapeutic agent to a subject. The ampoule filtration system includes a sterile filter cartridge attached to the mouth of an ampoule, such that liquid dispensed from the ampoule is drawn through the cartridge, and a means for sealingly engaging the filtration system to a delivery device.Type: GrantFiled: April 10, 2003Date of Patent: April 18, 2006Assignee: Pharmacia CorporationInventors: Robert H. Heyes, Peter N. Carpenter, Remo Ponta
-
Patent number: 6696426Abstract: There is provided a pharmaceutical preservative free composition suitable for topical administration to an eye, the composition comprising (a) an oxazolidinone antimicrobial drug, for example linezolid, in a therapeutically or prophylactically effective drug concentration that is above the practical limit of solubility of the drug in a substantially isotonic aqueous solution at a physiologically compatible pH, and (b) a pharmaceutically acceptable cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. The composition is particularly useful for the treatment and/or prevention of eye infections due to gram positive bacteria.Type: GrantFiled: February 22, 2002Date of Patent: February 24, 2004Assignee: Pharmacia CorporationInventors: Satish K. Singh, Lisa A. Adams, Paramita Bandyopadhyay, Syed Hasan, Leslie C. Hawley, Sandra M. Sims
-
Patent number: 6551584Abstract: There is provided a pharmaceutical composition suitable for topical administration to an eye, the composition comprising as active agent at least one oxazolidinone antibacterial drug, for example linezolid, in a concentration effective for treatment and/or prophylaxis of a gram-positive bacterial infection of an eye, and at least one ophthalmically acceptable excipient ingredient that reduces a rate of removal of the composition from the eye by lacrimation such that the composition has an effective residence time in the eye of about 2 to about 24 hours. The composition is, for example, an in situ gellable solution, suspension or solution/suspension.Type: GrantFiled: October 10, 2001Date of Patent: April 22, 2003Assignee: Pharmacia & Upjohn CompanyInventors: Rebanta Bandyopadhyay, Pamela J. Secreast, Leslie C. Hawley, Vincent E. McCurdy, Praveen Tyle, Paramita Bandyopadhyay, Satish Kumar Singh
-
Patent number: 6495157Abstract: A highly storage-stable composition for vaginal administration of clindamycin is disclosed which is useful for the treatment of bacterial vaginosis. The composition is a vaginal suppository containing an antimicrobially effective amount of clindamycin dispersed in a Hard Fat NF suppository base. Hard Fat NF suppository bases provide a clindamycin product having long term storage stability while providing efficacy against bacterial vaginosis which is equivalent to clindamycin vaginal creams.Type: GrantFiled: July 20, 2000Date of Patent: December 17, 2002Assignee: Pharmacia & Upjohn CompanyInventors: Lorraine Elisabeth Pena, Phil Bryan Bowman, Robert Shih-Liang Chao, Carolyn V. Pesheck
-
Patent number: 6479235Abstract: Methods and materials are disclosed for use in simultaneously amplifying at least thirteen loci of genomic DNA in a single multiplex reaction, as are methods and materials for use in the analysis of the products of such reactions. Included in the present invention are materials and methods for the simultaneous amplification of at least thirteen short tandem repeat loci, including specific materials and methods for the analysis of thirteen such loci specifically selected by the United States Federal Bureau of Investigation as core loci for use in the Combined DNA Index System (CODIS) database.Type: GrantFiled: November 25, 1998Date of Patent: November 12, 2002Assignee: Promega CorporationInventors: James W. Schumm, Cynthia J. Sprecher
-
Patent number: 6402887Abstract: A method using biological processes in the production of pulp from industrial wood waste is described. The process makes use of various species of white-rot fungi which selectively degrade lignin. The industrial wood waste must be cleaned and hydrated prior to inoculation with the fungus. Paper produced by this process has excellent strength characteristics as compared to both non-treated industrial wood waste and pulp produced from virgin wood chips. Substantial energy savings are also realized when the biopulped industrial wood waste chips are further refined by conventional mechanical pulping procedures. Kraft pulping of wood waste resulted in strength properties comparable to those of virgin wood. Fungal pretreatment subsequently enhanced the resulting kraft pulp properties.Type: GrantFiled: November 30, 1998Date of Patent: June 11, 2002Assignees: Biopulping International, Inc., The United States of America as represented by the Secretary of AgricultureInventors: Masood Akhtar, Gary M. Scott, Aziz Ahmed, Michael J. Lentz, Eric G. Horn
-
Patent number: 6365172Abstract: This invention relates to fiber-forming bioabsorbable poly(ester-amide)s made by the polymerization of diamidediols with 3,6-dioxaoctanedioic acid, also known as “triglycolic acid”. More specifically it relates to diol terminated poly(ester-amide)s of triglycolic acid that are optionally further reacted with glycolide, lactide, trimethylene carbonate, epsilon-caprolactone, or p-dioxanone, or mixtures of said cyclic monomers to produce the corresponding block copolymers. Said polymers are useful in the production of surgical sutures having superior performance characteristics including low bending stiffness and in the production of other fiber-based bioabsorbable implants and molded devices.Type: GrantFiled: August 1, 2000Date of Patent: April 2, 2002Assignee: BioAmide, Inc.Inventor: Thomas Harry Barrows
-
Patent number: 6350452Abstract: Disclosed are antibodies that specifically recognize the new amino terminus of a protein cleaved by a protease during apoptosis. Methods of using and making the antibodies are also provided. The antibodies are particularly useful in methods of detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis.Type: GrantFiled: December 8, 1999Date of Patent: February 26, 2002Assignee: Promega CorporationInventor: Terry Riss
-
Patent number: 6310199Abstract: pH dependent ion exchange matrices are provided, with methods for making such matrices, and methods for using such matrices to isolate a target nucleic acid, such as plasmid DNA, chromosomal DNA, or RNA from contaminants, including proteins, lipids, cellular debris, or other nucleic acids. Each pH dependent ion exchange matrix of this invention comprises at least two different ion exchange functional groups, one of which is capable of acting as an anion exchanger at a first pH, and the other of which is capable of acting as a cation exchanger at a second, higher pH. The matrix has an overall neutral charge in a pH range between the first and second pH. The pH dependent ion exchange matrices of the present invention are designed to bind to the target nucleic acid at a pH wherein the overall charge of the matrix is positive, and to release the target nucleic acid as the pH of the surrounding solution is increased.Type: GrantFiled: May 14, 1999Date of Patent: October 30, 2001Assignee: Promega CorporationInventors: Craig E. Smith, Diana L. Holmes, Daniel J. Simpson, Jehoshua Katzenhendler, Rex M. Bitner, Josephine C. Grosch
-
Patent number: 6284470Abstract: Methods are disclosed for using paramagnetic particles to concentrate or harvest cells. Methods are also disclosed for clearing a solution of disrupted biological material, such as a lysate of cells or a homogenate of mammalian tissue. Methods are also disclosed for using paramagnetic particles to isolate target nucleic acids, such as RNA or DNA, from a solution cleared of disrupted biological material using the same type or a different type of paramagnetic particle. Kits are also disclosed for use with the various methods of the present invention. Nucleic acids isolated according to the present methods and using the present kits are suitable for immediate use in downstream processing, without further purification.Type: GrantFiled: August 24, 2000Date of Patent: September 4, 2001Assignee: Promega CorporationInventors: Rex M. Bitner, Craig E. Smith, Douglas H. White, Braeden L. Butler, Jacqui Sankbeil
-
Patent number: 6270970Abstract: Mixed-bed solid phases are provided, with methods for using such solid phases to isolate target nucleic acids, such as plasmid DNA, chromosomal DNA, RNA, or nucleic acids generated by enzymatic amplification from contaminants, including proteins, lipids, cellular debris, or other nucleic acids. The mixed-bed solid phases of this invention are mixtures of at least two different solid phases, each of which has a capacity to bind to the target nucleic acid under different solution conditions, and the capacity to release the nucleic acid under similar elution conditions. By exchanging solution conditions according to the methods of this invention, one can remove contaminants from the target nucleic acid bound to the mixed-bed solid phase, then elute the target nucleic acid in an elution buffer.Type: GrantFiled: May 14, 1999Date of Patent: August 7, 2001Assignee: Promega CorporationInventors: Craig E. Smith, Diana L. Holmes, Daniel J. Simpson, Jehoshua Katzenhendler, Rex M. Bitner, Josephine C. Grosch
-
Patent number: 6238863Abstract: The present invention is directed to materials and methods for the identification and analysis of intermediate tandem repeat sequences in DNA, wherein an intermediate tandem repeat (ITR) sequence is a region of a DNA sequence containing at least one five to seven base repeat unit appearing in tandem at least two times. DNA markers to highly polymorphic ITR loci in the human genome are identified and analyzed, using particularly preferred embodiments of the materials and methods of the present invention.Type: GrantFiled: February 4, 1998Date of Patent: May 29, 2001Assignee: Promega CorporationInventors: James W. Schumm, Jeffery W. Bacher
-
Patent number: 6221598Abstract: The present invention is directed to the simultaneous amplification of multiple distinct genetic loci using PCR or other amplification systems to determine in one reaction the alleles of each locus contained within the multiplex.Type: GrantFiled: June 7, 1999Date of Patent: April 24, 2001Assignee: Promega CorporationInventors: James W. Schumm, Cynthia J. Sprecher, Ann M. Lins